Rodan + Fields Concealed Prostaglandin Risks From Lash Boost Users – Class Action
This article was originally published in The Rose Sheet
Marketers of cosmetic lash enhancers that haven’t abandoned prostaglandin analogs in favor of peptides or botanical extracts should take heed of a proposed class action against Rodan + Fields in California’s Northern District. Plaintiffs say they would not have purchased the firm’s Lash Boost and suffered alleged adverse effects if they’d been properly informed about product risks.
You may also be interested in...
Marketers of cosmetic products that rely on prostaglandins or their analogues to grow eyelashes – or compete against companies that use the ingredients – have until 22 October to submit information to the Commission, which will help inform an assessment by the Scientific Committee on Consumer Safety.
Direct seller launched a preemptive strike last year against a professional stylist for her allegations that Monat hair products cause hair loss and other damage "just like WEN." In recent weeks, the firm has lodged more defamation suits against individuals, while plaintiffs have begun filing proposed class actions against Monat in Florida federal court
A link for FDA information included in Prop 65 warnings for Rodan & Fields benzophenone products went an industry site, the Environmental Working Group found. The firm replaced the link with one to FDA’s site, saying it used the industry website because it was more consumer friendly.